Tapewire

NYSE · USD

XRN

Chiron Real Estate Inc.

Export transactions ↓
Tapewire entity
5421
SEC CIK
0001533615
Parsed reports
218

Last 12 months

Inside the activity.

25 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202510
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 2026130
Jun 202600
Jul 202600
Aug 202680
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 14, 2025 Filed Nov 18, 2025 01:08 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 4,093 $32.41 $132,654.13
Disclosure

SEC source: 0001104659-25-113327 · tm2531517-1_4seq1.xml · nonDerivative · entry 1

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,867

F1 · balance_after: Shares are reflected on a post-split basis in accordance with the 1-for-5 reverse stock split of the Issuer's issued and outstanding shares of common stock completed on September 19, 2025, including the Reporting Person's receipt of cash in lieu of a fractional share.

Read SEC document
August 26, 2025 Filed Aug 26, 2025 21:13 UTC PurchaseCommon Stock 1,350 $7.38 $9,960.44
Disclosure

SEC source: 0001104659-25-083143 · tm2524427-1_4seq1.xml · nonDerivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,350

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:15 UTC
Barber Jamie AllenGeneral Counsel and Secretary
SaleCommon Stock 130,000 $6.62 $861,068.00
Disclosure

SEC source: 0001104659-25-079799 · tm2523767-2_4seq1.xml · nonDerivative · entry 1

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: This is the weighted average price. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The amount reflected has been rounded to four decimal points.

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:15 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 17,023 $6.87 $116,948.01
Disclosure

SEC source: 0001104659-25-079792 · tm2523767-1_4seq1.xml · nonDerivative · entry 2

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 190,894

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:15 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 13,871 $6.84 $94,877.64
Disclosure

SEC source: 0001104659-25-079792 · tm2523767-1_4seq1.xml · nonDerivative · entry 1

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,871

Read SEC document
August 07, 2025 Filed Aug 8, 2025 20:01 UTC
Barber Jamie AllenGeneral Counsel and Secretary
Exercise / conversionOP Unit · Derivative 130,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · derivative · entry 4

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 130,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F4 · price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

F4 · derivative.exercise_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

F4 · derivative.expiration_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

Read SEC document
August 07, 2025 Filed Aug 8, 2025 20:01 UTC
Barber Jamie AllenGeneral Counsel and Secretary
Exercise / conversionOP Unit · Derivative 130,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · derivative · entry 3

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F4 · price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

F4 · derivative.exercise_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

F4 · derivative.expiration_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date.

Read SEC document
August 07, 2025 Filed Aug 8, 2025 20:01 UTC
Barber Jamie AllenGeneral Counsel and Secretary
Exercise / conversionLTIP Unit · Derivative 130,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · derivative · entry 2

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,573

Underlying: Common Stock · 130,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents LTIP Units in the OP. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F3 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for an equivalent number of OP Units. OP Units may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. LTIP Units have no expiration date.

F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F3 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for an equivalent number of OP Units. OP Units may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: Represents LTIP Units in the OP. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F3 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for an equivalent number of OP Units. OP Units may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
August 07, 2025 Filed Aug 8, 2025 20:01 UTC
Barber Jamie AllenGeneral Counsel and Secretary
Exercise / conversionCommon Stock 130,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · nonDerivative · entry 1

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement.

Read SEC document
June 25, 2025 Filed Jun 26, 2025 00:24 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 18,503 $6.54 $120,991.12
Disclosure

SEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 5

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

F5 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.4925 to $6.615, inclusive. The amount reflected has been rounded to four decimal points.

Read SEC document
June 25, 2025 Filed Jun 26, 2025 00:24 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 8,072 $6.56 $52,980.57
Disclosure

SEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 4

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,497

F4 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.555 to $6.585, inclusive. The amount reflected has been rounded to four decimal points.

Read SEC document
June 25, 2025 Filed Jun 26, 2025 00:24 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 30,757 $6.47 $198,862.46
Disclosure

SEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 3

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,425

F3 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.44 to $6.505, inclusive. The amount reflected has been rounded to four decimal points.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 00:24 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 2,668 $6.37 $16,993.83
Disclosure

SEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 2

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,668

F2 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.32 to $6.40, inclusive. The amount reflected has been rounded to four decimal points.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 00:24 UTC
Decker Mark Okey JrDirector · CEO and President
PurchaseCommon Stock 100,000 $6.53 $652,700.00
Disclosure

SEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 1

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.31 to $6.60, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to Global Medical REIT Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (5) to this Form 4.

Read SEC document
June 23, 2025 Filed Jun 26, 2025 00:24 UTC
Decker Mark Okey JrDirector · CEO and President
GrantLTIP Unit (Right to Buy) · Derivative 158,730 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · derivative · entry 6

Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,730

Underlying: Common Stock · 158,730 shares

Expires not disclosed

F6 · security: Represents units of limited partnership interests ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) in connection with the Reporting Person's appointment as President and Chief Executive Officer, effective June 23, 2025 (the "grant date"). All of the LTIP Units vest on the third anniversary of the grant date.

F7 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F7 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F7 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 14, 2025 Filed May 15, 2025 12:16 UTC GrantLTIP Unit (Right to Buy) · Derivative 11,518 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-049024 · tm2515150-4_4seq1.xml · derivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,526

Underlying: Common Stock · 11,518 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 14, 2025 Filed May 15, 2025 12:18 UTC
Wittman LoriDirector
GrantLTIP Unit (Right to Buy) · Derivative 11,518 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-049026 · tm2515150-6_4seq1.xml · derivative · entry 1

Wittman Lori · CIK 0001615562 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,581

Underlying: Common Stock · 11,518 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 14, 2025 Filed May 15, 2025 12:17 UTC GrantLTIP Unit (Right to Buy) · Derivative 11,518 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-049025 · tm2515150-5_4seq1.xml · derivative · entry 1

Marston Ronald · CIK 0001652392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,526

Underlying: Common Stock · 11,518 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 14, 2025 Filed May 15, 2025 12:14 UTC GrantLTIP Unit (Right to Buy) · Derivative 11,518 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-049021 · tm2515150-3_4seq1.xml · derivative · entry 1

Crowley Paula · CIK 0001743595 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,581

Underlying: Common Stock · 11,518 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 14, 2025 Filed May 15, 2025 12:12 UTC
Cole HenryDirector
GrantLTIP Unit (Right to Buy) · Derivative 11,518 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-049017 · tm2515150-2_4seq1.xml · derivative · entry 1

Cole Henry · CIK 0001652393 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,526

Underlying: Common Stock · 11,518 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 20:49 UTC
Busch JeffreyDirector · Chairman, President and CEO
GrantLTIP Unit (Right to Buy) · Derivative 23,613 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018541 · tm257884-1_4seq1.xml · derivative · entry 1

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 745,015

Underlying: Common Stock · 23,613 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:51 UTC
KIERNAN ROBERT JCFO and Treasurer
GrantLTIP Unit (Right to Buy) · Derivative 13,493 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018542 · tm257884-2_4seq1.xml · derivative · entry 2

KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 428,374

Underlying: Common Stock · 13,493 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:51 UTC
KIERNAN ROBERT JCFO and Treasurer
GrantLTIP Unit (Right to Buy) · Derivative 46,069 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018542 · tm257884-2_4seq1.xml · derivative · entry 1

KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,881

Underlying: Common Stock · 46,069 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:55 UTC
Barber Jamie AllenGeneral Counsel and Secretary
GrantLTIP Unit (Right to Buy) · Derivative 7,826 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018547 · tm257884-5_4seq1.xml · derivative · entry 2

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,573

Underlying: Common Stock · 7,826 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:55 UTC
Barber Jamie AllenGeneral Counsel and Secretary
GrantLTIP Unit (Right to Buy) · Derivative 24,570 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018547 · tm257884-5_4seq1.xml · derivative · entry 1

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,747

Underlying: Common Stock · 24,570 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:53 UTC
Holley DanicaChief Operating Officer
GrantLTIP Unit (Right to Buy) · Derivative 8,770 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018544 · tm257884-4_4seq1.xml · derivative · entry 2

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,620

Underlying: Common Stock · 8,770 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:53 UTC
Holley DanicaChief Operating Officer
GrantLTIP Unit (Right to Buy) · Derivative 25,799 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018544 · tm257884-4_4seq1.xml · derivative · entry 1

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,850

Underlying: Common Stock · 25,799 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:52 UTC
Leon AlfonzoChief Investment Officer
GrantLTIP Unit (Right to Buy) · Derivative 12,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018543 · tm257884-3_4seq1.xml · derivative · entry 2

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457,283

Underlying: Common Stock · 12,650 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 01:52 UTC
Leon AlfonzoChief Investment Officer
GrantLTIP Unit (Right to Buy) · Derivative 46,069 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-018543 · tm257884-3_4seq1.xml · derivative · entry 1

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,633

Underlying: Common Stock · 46,069 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 15, 2024 Filed May 16, 2024 21:36 UTC GrantLTIP Unit (Right to Buy) · Derivative 9,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-062632 · tm2414766-2_4seq1.xml · derivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,008

Underlying: Common Stock · 9,316 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 15, 2024 Filed May 16, 2024 21:39 UTC GrantLTIP Unit (Right to Buy) · Derivative 9,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-062637 · tm2414766-5_4seq1.xml · derivative · entry 1

Marston Ronald · CIK 0001652392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,008

Underlying: Common Stock · 9,316 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 15, 2024 Filed May 16, 2024 21:38 UTC GrantLTIP Unit (Right to Buy) · Derivative 9,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-062636 · tm2414766-4_4seq1.xml · derivative · entry 1

Crowley Paula · CIK 0001743595 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,063

Underlying: Common Stock · 9,316 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 15, 2024 Filed May 16, 2024 21:37 UTC
Wittman LoriDirector
GrantLTIP Unit (Right to Buy) · Derivative 9,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-062635 · tm2414766-3_4seq1.xml · derivative · entry 1

Wittman Lori · CIK 0001615562 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,063

Underlying: Common Stock · 9,316 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 15, 2024 Filed May 16, 2024 21:34 UTC
Cole HenryDirector
GrantLTIP Unit (Right to Buy) · Derivative 9,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-062631 · tm2414766-1_4seq1.xml · derivative · entry 1

Cole Henry · CIK 0001652393 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,008

Underlying: Common Stock · 9,316 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 16:06 UTC
Busch JeffreyDirector · Chairman, President and CEO
GrantLTIP Unit (Right to Buy) · Derivative 29,384 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027016 · tm247073-2_4seq1.xml · derivative · entry 2

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 721,402

Underlying: Common Stock · 29,384 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 16:06 UTC
Busch JeffreyDirector · Chairman, President and CEO
GrantLTIP Unit (Right to Buy) · Derivative 62,176 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027016 · tm247073-2_4seq1.xml · derivative · entry 1

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 692,018

Underlying: Common Stock · 62,176 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:08 UTC
KIERNAN ROBERT JCFO and Treasurer
GrantLTIP Unit (Right to Buy) · Derivative 18,549 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027023 · tm247073-4_4seq1.xml · derivative · entry 2

KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,812

Underlying: Common Stock · 18,549 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:08 UTC
KIERNAN ROBERT JCFO and Treasurer
GrantLTIP Unit (Right to Buy) · Derivative 38,860 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027023 · tm247073-4_4seq1.xml · derivative · entry 1

KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,263

Underlying: Common Stock · 38,860 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:09 UTC
Leon AlfonzoChief Investment Officer
GrantLTIP Unit (Right to Buy) · Derivative 15,742 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027025 · tm247073-5_4seq1.xml · derivative · entry 2

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,564

Underlying: Common Stock · 15,742 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:09 UTC
Leon AlfonzoChief Investment Officer
GrantLTIP Unit (Right to Buy) · Derivative 38,860 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027025 · tm247073-5_4seq1.xml · derivative · entry 1

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,822

Underlying: Common Stock · 38,860 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:06 UTC
Holley DanicaChief Operating Officer
GrantLTIP Unit (Right to Buy) · Derivative 11,486 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027020 · tm247073-3_4seq1.xml · derivative · entry 2

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,051

Underlying: Common Stock · 11,486 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:06 UTC
Holley DanicaChief Operating Officer
GrantLTIP Unit (Right to Buy) · Derivative 21,762 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027020 · tm247073-3_4seq1.xml · derivative · entry 1

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,565

Underlying: Common Stock · 21,762 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:06 UTC
Barber Jamie AllenGeneral Counsel and Secretary
GrantLTIP Unit (Right to Buy) · Derivative 10,249 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027014 · tm247073-1_4seq1.xml · derivative · entry 2

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,177

Underlying: Common Stock · 10,249 shares

Expires not disclosed

F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:06 UTC
Barber Jamie AllenGeneral Counsel and Secretary
GrantLTIP Unit (Right to Buy) · Derivative 20,725 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-027014 · tm247073-1_4seq1.xml · derivative · entry 1

Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,928

Underlying: Common Stock · 20,725 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:56 UTC GrantLTIP Unit (Right to Buy) · Derivative 8,903 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-058497 · tm2315309-3_4seq1.xml · derivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,692

Underlying: Common Stock · 8,903 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:56 UTC
Wittman LoriDirector
GrantLTIP Unit (Right to Buy) · Derivative 8,903 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-058501 · tm2315309-5_4seq1.xml · derivative · entry 1

Wittman Lori · CIK 0001615562 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,747

Underlying: Common Stock · 8,903 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:55 UTC GrantLTIP Unit (Right to Buy) · Derivative 8,903 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-058496 · tm2315309-2_4seq1.xml · derivative · entry 1

Crowley Paula · CIK 0001743595 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,747

Underlying: Common Stock · 8,903 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:56 UTC GrantLTIP Unit (Right to Buy) · Derivative 8,903 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-058498 · tm2315309-4_4seq1.xml · derivative · entry 1

Marston Ronald · CIK 0001652392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,692

Underlying: Common Stock · 8,903 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
May 10, 2023 Filed May 10, 2023 20:54 UTC
Cole HenryDirector
GrantLTIP Unit (Right to Buy) · Derivative 8,903 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-058494 · tm2315309-1_4seq1.xml · derivative · entry 1

Cole Henry · CIK 0001652393 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,692

Underlying: Common Stock · 8,903 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document
February 28, 2023 Filed Feb 28, 2023 19:18 UTC
Busch JeffreyDirector · Chairman, President and CEO
GrantLTIP Unit (Right to Buy) · Derivative 13,175 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-026874 · tm238076-1_4seq1.xml · derivative · entry 1

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 629,842

Underlying: Common Stock · 13,175 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.